Markets & Regulations

Approvals of orphan drugs will continue to rise in 2015, says Frost & Sullivan

Novel orphan drug boom in 2015, predict experts

By Anthony King

The pharma industry reached a high water mark in 2014 with a record number of new molecular entities approved by the US Food and Drug Administration, especially orphan drugs.

Follow us


View more